|
|
| Line 1: |
Line 1: |
| == SKI protein ==
| |
| <Structure load='1sbx' size='500' frame='true' align='right' caption='Crystal Structure of human SKI, PDB ID: 1SBX' scene='Insert optional scene name here' /><!-- PLEASE DO NOT DELETE THIS TEMPLATE -->
| |
| {{Sandbox_Reserved_Irma_Santoro_7}}
| |
| <!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
| |
|
| |
|
| == Background ==
| |
| The SKI protein was first identified as an oncoprotein. An oncoprotein is one that has the potential to cause abnormal cellular proliferation if mutated or if expressed in quantitative amounts. Although, for a time the method by which the SKI protein acquired such capabilities was unknown, it was recently discovered that SKI interacts with smad after stimulation by TGF-beta. TGF-beta are proteins directly associated with proliferation and cellular differentiation, while smads are transcription factors that transduce transforming growth factor-betar(TGF-beta) members to activate transcription. SKI blocks the activation of transcription witht eh smad complexes which makes the cells resistant to the inhibitory reactions of normal growth induced by TGF-beta. Note that the stimulation of TGF-beta may cause the rapid degradation of SKI. However, after a relatively brief amount of time its expression is strongly induced. <ref name="SKI protein"> Reed JA, Lin Q, Chen D, Mian IS, Medrano EE. SKI Pathways Inducing Progression of Human Melanoma. June 2005. http://www.ncbi.nlm.nih.gov/pubmed/15986136</ref>.
| |
|
| |
| == Structure ==
| |
| This protein is made up of 728 amino acids <ref name="SKI protein structure"> Wilson JJ, Malakhova M, Zhang R, Joachimiak A, Hedge RS. May 2004. "Crystal Struture of the Dachshund homology domain of human SKI" Structure 12 (5):785-92. http://www.ncbi.nlm.nih.gov/pubmed/15130471>. The SKI protein maintains several domains that include the amino-terminus, a proline rich area, helix-loop-helix motifs, a cysteine/histidine-rich area, a region of basic amino acids and finally a leucine zipper-like domain. <ref name="SKI protein str."> Zheng G, Teumer J, Colmenares C, Richmond C and Stavnezer E. 1997. Oncogene. http://www.nature.com/onc/journal/v22/n20/full/1206452a.html>
| |
|
| |
| == Function ==
| |
| SKI, as mentioned before is an oncoprotein that represses TGF-beta and nuclear receptor signaling. It is involved in the regulation of cellular transformation and differentiation. The SKI protein has been associated with tumors at large levels of cellular concentrations and it has been shown to interfere with normal cellular functioning. It was recently discovred that SKI plays a role not only inside the nucleus but also outside of the nucleus in the cytoplasm.
| |
|
| |
| == Clinical Applications ==
| |
| SKI has been linked to various types of cancer such as melanoma, esophageal cell carcinoma, cervical cancer and the process of tumor progresssion. The SKI oncoprotein has been demonstrated to assist tyrosine kinases to cause leukemia, recently it has been demonstrated that the protein also plays a regulatory role in several signal transduction pathways that are frequent targets for mutagenesis in human tumors.
| |
|
| |
| == References ==
| |
|
| |
| <references/>
| |